| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.258 | 22.837 | 24.854 | 36.641 | 38.909 | 39.672 | 47.721 | 71.031 | 89.398 | 85.815 |
| Total Income - EUR | 12.258 | 22.837 | 24.854 | 36.641 | 38.913 | 42.792 | 47.730 | 71.716 | 89.404 | 85.818 |
| Total Expenses - EUR | 6.729 | 13.892 | 12.365 | 13.061 | 16.044 | 27.155 | 27.437 | 23.157 | 62.157 | 44.262 |
| Gross Profit/Loss - EUR | 5.529 | 8.945 | 12.489 | 23.580 | 22.869 | 15.638 | 20.293 | 48.559 | 27.247 | 41.557 |
| Net Profit/Loss - EUR | 5.179 | 8.488 | 12.137 | 23.214 | 22.480 | 15.241 | 19.815 | 47.841 | 26.371 | 37.633 |
| Employees | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 3 |
Check the financial reports for the company - Med Dr. Moraru Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 223 | 179 | 109 | 107 | 105 | 0 | 0 | 970 | 645 | 214 |
| Current Assets | 5.768 | 12.835 | 26.209 | 24.269 | 47.220 | 61.795 | 75.199 | 59.076 | 32.390 | 43.011 |
| Inventories | 0 | 31 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14 |
| Receivables | 1.051 | 3.977 | 7.636 | 9.924 | 16.922 | 4.129 | 2.788 | 41.218 | 9.379 | 25.948 |
| Cash | 4.716 | 8.827 | 18.573 | 14.345 | 30.298 | 36.993 | 31.980 | 17.858 | 23.011 | 17.049 |
| Shareholders Funds | 5.224 | 8.533 | 20.560 | 23.264 | 45.294 | 59.561 | 73.532 | 47.890 | 26.420 | 39.238 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 766 | 4.482 | 5.759 | 1.112 | 2.032 | 2.234 | 1.667 | 12.156 | 7.116 | 4.051 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Med Dr. Moraru Srl